0001209191-23-018225.txt : 20230313 0001209191-23-018225.hdr.sgml : 20230313 20230313171058 ACCESSION NUMBER: 0001209191-23-018225 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230303 FILED AS OF DATE: 20230313 DATE AS OF CHANGE: 20230313 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Narido Richard Clavano CENTRAL INDEX KEY: 0001956050 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39976 FILM NUMBER: 23728169 MAIL ADDRESS: STREET 1: 1412 62ND STREET CITY: EMERYVILLE STATE: CA ZIP: 94608 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Lucira Health, Inc. CENTRAL INDEX KEY: 0001652724 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 272491037 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1315 63RD STREET CITY: EMERYVILLE STATE: CA ZIP: 94608 BUSINESS PHONE: (814) 574-1546 MAIL ADDRESS: STREET 1: 1315 63RD STREET CITY: EMERYVILLE STATE: CA ZIP: 94608 FORMER COMPANY: FORMER CONFORMED NAME: DiAssess Inc. DATE OF NAME CHANGE: 20150908 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-03-03 0 0001652724 Lucira Health, Inc. LHDX 0001956050 Narido Richard Clavano 1412 62ND ST EMERYVILLE CA 94608 0 1 0 0 Chief Financial Officer Common Stock 2023-03-03 4 S 0 10674 1.14 D 96619 D Common Stock 2023-03-03 4 S 0 9675 1.07 D 86944 D Common Stock 2023-03-03 4 S 0 4742 1.00 D 82202 D Common Stock 2023-03-06 4 S 0 1910 0.57 D 80292 D Common Stock 2023-03-07 4 S 0 2382 0.45 D 77910 D /s/ Richard Narido 2023-03-13